Followers | 4051 |
Posts | 152184 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |
Tuesday, May 30, 2023 8:02:40 AM
Recent ACON News
- Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes • GlobeNewswire Inc. • 09/27/2024 10:57:00 AM
- PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology • GlobeNewswire Inc. • 09/13/2024 12:30:00 PM
- Aclarion Provides Corporate Update on Nociscan AI Technology Milestones • GlobeNewswire Inc. • 09/12/2024 10:57:00 AM
- Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial • GlobeNewswire Inc. • 09/10/2024 10:57:00 AM
- Aclarion Added to PRISM Emerging Medical Devices Index • GlobeNewswire Inc. • 09/06/2024 03:27:33 PM
- Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market • GlobeNewswire Inc. • 09/05/2024 10:57:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:01:26 PM
- Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey • GlobeNewswire Inc. • 08/29/2024 10:57:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/26/2024 08:02:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:58:12 PM
- Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans • GlobeNewswire Inc. • 08/21/2024 11:57:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:56:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2024 08:01:01 PM
- Aclarion to Present at August 20th Virtual Investor Summit Microcap Event • GlobeNewswire Inc. • 08/15/2024 01:48:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 07:34:17 PM
- Aclarion Announces First Commercial Agreement in Michigan • GlobeNewswire Inc. • 08/14/2024 12:08:00 PM
- Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK • GlobeNewswire Inc. • 08/13/2024 01:07:00 PM
- Form 253G3 - • Edgar (US Regulatory) • 08/13/2024 01:05:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/13/2024 11:56:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:02:13 PM
- Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK • GlobeNewswire Inc. • 07/09/2024 11:00:00 AM
- Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK • GlobeNewswire Inc. • 06/26/2024 12:30:00 PM
- Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
- Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain • GlobeNewswire Inc. • 04/25/2024 01:14:37 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/06/2024 09:09:09 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM